Discover how Cambridge is bringing together leading organisations to form ClinSilico, a new consortium focused on developing new AI tools to make clinical trials quicker, cheaper and more successful. Hear what ClinSilico aims to build, and what action is needed to unlock investment and accelerate delivery at scale.